Abstract: Narrow passage scenarios pose significant challenges for path planning, especially for tasks requiring real-time performance. Traditional asymptotically converging sampling-based planners ...

WASHINGTON, Feb 3 (Reuters) - The U.S. government and a majority of U.S. states on Tuesday will appeal the outcome of a landmark antitrust case against Alphabet's (GOOGL.O), opens new tab Google, ...

SandR is a utility for recursive search and replace operations on text files in Windows using regular expressions. SandR Recursive Search and Replace Utility SandR is a software utility designed for ...

Mr. Shirky, a vice provost at New York University, has been helping faculty members and students adapt to digital tools since 2015. Back in 2023, when ChatGPT was still new, a professor friend had a ...

A security vulnerability has been disclosed in the popular binary-parser npm library that, if successfully exploited, could result in the execution of arbitrary JavaScript. The vulnerability, tracked ...

The percentage of teachers who are using artificial intelligence-driven tools in their classrooms nearly doubled between 2023 and 2025, according to data from the EdWeek Research Center. In 2023, a ...

Consumers are increasingly using AI tools — not Google — as their first source of information. This is driven by frustration with traditional search and rising expectations that AI will play a much ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...